Clinical Trial Update: A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nontuberculous Mycobacterium Infection
• Pulmonary Nontuberculous Mycobacterial Infection

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Nontuberculous Mycobacterium Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-05-18